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Abstract
The Clostridium perfringens e-toxin is an extremely potent toxin associated with lethal toxemias in domesticated ruminants
and may be toxic to humans. Intoxication results in fluid accumulation in various tissues, most notably in the brain and
kidneys. Previous studies suggest that the toxin is a pore-forming toxin, leading to dysregulated ion homeostasis and
ultimately cell death. However, mammalian host factors that likely contribute to e-toxin-induced cytotoxicity are poorly
understood. A library of insertional mutant Madin Darby canine kidney (MDCK) cells, which are highly susceptible to the
lethal affects of e-toxin, was used to select clones of cells resistant to e-toxin-induced cytotoxicity. The genes mutated in 9
surviving resistant cell clones were identified. We focused additional experiments on one of the identified genes as a means
of validating the experimental approach. Gene expression microarray analysis revealed that one of the identified genes,
hepatitis A virus cellular receptor 1 (HAVCR1, KIM-1, TIM1), is more abundantly expressed in human kidney cell lines than it is
expressed in human cells known to be resistant to e-toxin. One human kidney cell line, ACHN, was found to be sensitive to
the toxin and expresses a larger isoform of the HAVCR1 protein than the HAVCR1 protein expressed by other, toxin-resistant
human kidney cell lines. RNA interference studies in MDCK and in ACHN cells confirmed that HAVCR1 contributes to e-toxin-
induced cytotoxicity. Additionally, e-toxin was shown to bind to HAVCR1 in vitro. The results of this study indicate that
HAVCR1 and the other genes identified through the use of gene-trap mutagenesis and RNA interference strategies
represent important targets for investigation of the process by which e-toxin induces cell death and new targets for
potential therapeutic intervention.
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Introduction
The Clostridium perfringens e-toxin is responsible for a lethal
enterotoxemia in livestock animals, and possibly in humans [1].
The U.S. Department of Health and Human Services has
classified the e-toxin as a select agent. Intoxication leads to
increased permeability of the small intestine and ultimately causes
widespread vascular permeability [2,3,4,5,6]. The toxin is believed
to enter into the bloodstream and disseminate throughout the
body where it accumulates primarily in the kidneys and brain of
intoxicated animals [4,7,8]. Symptoms of e-toxin intoxication
typically indicate central nervous system involvement and may
include incoordination, convulsions, or coma before death
[9,10,11]. As is true of many select agents and toxins, human
exposure to e-toxin appears to be rare. In contrast to sheep and
other livestock, humans are infrequently infected by C. perfringens
strains capable of expressing e-toxin [12,13]. Studies do suggest,
however, that e-toxin may contribute to adverse health effects in
humans. At least two case studies provide evidence of e-toxin
production in humans [14,15], and additional case studies with
diverse clinical outcomes have reported human infection by
e-toxin-producing strains of C. perfringens (e.g., [16,17]). Many case
studies of C. perfringens infection do not provide information
concerning the toxins produced by the isolated strains. Although
natural infection of humans by e-toxin-producing C. perfringens is
rare, weaponization of the purified e-toxin could present the toxin
at either higher doses and via routes of exposure not normally
encountered and thus could present unique challenges to humans
exposed to the toxin. No therapy to counteract e-toxin is approved
for use in humans.
Though detailed binding studies have not been reported,
evidence from numerous studies suggests that e-toxin binds to a
specific receptor. The toxin is secreted from C. perfringens as a
relatively inactive precursor or prototoxin. In mice, toxin binding
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prototoxin [7,18]. Similarly, binding of the toxin to isolated
membranes is saturable and is inhibited by inactive e-prototoxin
[19]. Treatment of membrane fractions with pronase or neurami-
nidase decreases toxin binding, suggesting that a sialoglycoprotein
is the cell-surface receptor [19]. However, the identity of the
receptor remains to be determined.
The events leading to cell death in response to e-toxin are not
thoroughly understood, and multiple pathways of cell death may
be involved. Addition of e-toxin to MDCK cells leads to the
formation of detergent-resistant toxin oligomers [20,21,22].
Formation of the oligomeric complexes is detectable as early as
15 minutes after toxin addition to MDCK cells, at which time 10
to 20% of the monolayer has been killed [22]. Formation of these
oligomeric complexes is observed when e-toxin is added to
sensitive, but not resistant, cell lines [21]. In addition, the active
form of e-toxin, but not the inactive prototoxin, is able to form the
detergent-resistant complexes [21]. Specifically, removal of a
carboxy-terminal peptide from the e-prototoxin upon activation is
required for both the increased cytotoxicity and the ability to form
oligomeric complexes [20]. Treating MDCK cells with e-toxin is
rapidly followed by efflux of intracellular K
+ and increases in
intracellular Cl
2 and Na
+ [22,23]. There is no evidence that the
e-toxin enters cells [21,22,24]. Thus, in one pathway, the lethal
activity of the toxin may be a direct effect of the toxin forming
oligomeric pores in the plasma membrane of target cells, leading
to depolarization of the cell’s electrochemical gradient, disruption
of ion homeostasis, and cell death. However, an alternate pathway
leading to cell death also may be involved. Addition of e-toxin to a
murine renal cortical collecting duct cell line leads to a rapid
depletion of cellular ATP levels, stimulates AMP-activated protein
kinase, and induces nuclear translocation of apoptosis-inducing
factor, a potent caspase-independent cell death effector [25]. In
this latter study, the ATP-depletion and cell death appeared to be
independent of toxin oligomerization and the formation of pores
[25]. Thus host factors, in addition to the cell-surface receptor,
may contribute to e-toxin-mediated cytotoxicity.
A variety of studies exploring the cytotoxic activities of other
pore-forming toxins suggest that host factors (beyond cell-surface
receptors) also contribute to toxin-induced cytotoxicity [26,27,28,
29,30,31,32,33]. For example, the mammalian protein kinase A
pathway has been shown to be required for Cry1Ab-induced cell
death [31]. Additionally, E. coli a-hemolysin has been shown to
lead to leakage of ATP from cells; the extracellular ATP then
activates P2X pores that potentiate cell lysis [32]. Finally, pre-
treatment of glioma cells with inhibitors of mitogen-activated/
extracellular regulated kinase 1, protein kinase C, or Ca
2+/
calmodulin-dependent kinase II protects cells from Bc2 and
equinatoxin-II [33]. These previous studies indicate that the
mechanism by which pore-forming toxins mediate cell death is
more complicated than previously thought and that inhibition of
cellular responses can protect from cell death induced by pore-
forming toxins. Thus, identifying host factors contributing to the
activity of pore-forming toxins is expected to identify candidates
for new therapeutic approaches. Previous studies have used
forward genetic screens in hypodiploid cell lines to identify host
factors involved in the activity of bacterial protein toxins [34,35].
Although successful, the use of hypodiploid cell lines limits the
utility of these approaches.
In the present study, we use gene trap selection in a diploid cell
line to identify mammalian factors contributing to e-toxin-induced
cytotoxicity. Analysis of gene expression microarray data in
human cell lines led us to focus on one of the identified genes,
HAVCR1, and to the identification of a human cell line that is
sensitive to e-toxin. We confirmed a role for HAVCR1 in e-toxin-
induced cytotoxicity using shRNA in both canine and human cell
lines and demonstrated that e-toxin binds to HAVCR1 in vitro.
Results
Identification of mammalian genes by gene-trap
mutagenesis and selection of e-toxin-resistant MDCK
cells
To identify mammalian host factors contributing to e-toxin-
induced cytotoxicity, we used a genetic selection to isolate toxin-
resistant MDCK cells. Gene trap insertional mutagenesis involves
infection of a mammalian cell with a replication-deficient retro-
viral vector that integrates its genetic material into the host cell
chromosome with no known site specificity, carrying with it a
promoterless neomycin resistance gene (neo
r) [36]. Insertion of the
gene trap vector into an actively transcribed region of the
chromosome is expected to confer resistance to neomycin (G418)
and to disrupt expression of the gene into which the vector has
inserted. We have applied this approach to identify mammalian
genes whose disruption confers increased resistance to challenge
with purified e-toxin.
A gene trap library was generated in MDCK cells, a cell line
widely used in studies of e-toxin activity in vitro [37]. Following
infection with the gene trap vector and selection of G418-resistant
cells, the cells were incubated in medium containing e-toxin as
described in Materials and Methods. Cells that survived the toxin
challenge were cloned, and the sensitivity of the cloned cell lines to e-
toxin was assessed by incubating the cells with serial dilutions of
purified toxin (Figure 1). Though each of the selected mutant
MDCK cells displayed increased resistance to epsilon toxin, none
were as resistant as naturally-occurring resistant cell lines (data not
shown).Thismaybedue,atleastinpart,toexpressionfromthenon-
mutated allele following gene-trap insertional mutagenesis (if the
second allele is transcribed, then a reduction in expression, rather
than full knockdown is anticipated, with a resultant diminution of
toxin activity rather than full resistance to intoxication). It also is
possible that the naturally-resistant cell lines lack multiple factors
required for e-toxin-induced cytotoxicity. The disrupted genes
(identified as described in Materials and Methods) are listed in
Table 1 and include the gene encoding sphingomyelin synthase 2,
responsible for the last step in the synthesis of sphingomyelin.
Previous studies have demonstrated that inhibition of sphingomyelin
synthesis leads to increased resistance to e-toxin [38].
Identification of a human cell line sensitive to e-toxin
One difficulty in using MDCK cells to study the effects of e-
toxin on mammalian cells is the scarcity of reagents (e.g., antibodies
and shRNA) to canine proteins and genes. Such studies would be
aided by the identification of a human cell line that is sensitive to
the toxin. However, most cell lines tested appear resistant to e-
toxin, despite many being derived from organs and tissues that are
susceptible to and damaged by e-toxin in vivo. Other than MDCK
cells, published reports identify only two alternative cell lines that
are sensitive to e-toxin [25,39]. Like MDCK cells, both of these
cell lines are derived from kidney: one is derived from mouse
kidney, and the other is the human renal leiomyoblastoma cell
line, G-402. In contrast to MDCK cells, G-402 cells are reported
to require 160-times more e-toxin to kill than MDCK cells [39].
We therefore sought to identify an alternative human cell line that
might be more sensitive to e-toxin in which to study the genes
identified in our gene-trap selection.
We hypothesized that many human cell lines are resistant to e-
toxin-induced cytotoxicity because they fail to express one or more
Host Factors Contributing to e-Toxin Activity
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hypothesis, we used publicly-available microarray expression data
from 83 human cell lines representing different tissues [40,41].
Expression data was available for 8 of the genes listed in Table 1.
Gene expression levels among cells with unknown sensitivity to e-
toxin were compared to the expression levels among cell lines
known to be resistant to the toxin (HEK-293, HeLa, and A549)
([39] and data not shown). Results revealed one gene, HAVCR1,i s
expressed at higher levels in a number of human kidney cells than
it is expressed in three human cell lines known to be resistant to e-
toxin (Figure 2).
To identify one or more human kidney cell lines susceptible to
e-toxin, several kidney cell lines expected to express HAVCR1
were tested for toxin sensitivity. We found that one of the cell lines,
ACHN, is sensitive to e-toxin-induced cytotoxicity (Figure 3A),
whereas G-402 and other cell lines examined were resistant to e-
toxin at the doses tested. Immunoblotting with an anti-HAVCR1
antibody was used to examine the expression of HAVCR1 among
the cell lines tested. Results revealed that ACHN cells express a
,100 kDa variant of HAVCR1 (Figure 3B). In contrast, cell lines
resistant to e-toxin express either no detectable HAVCR1 or a
shorter, ,90 kDa variant (Figure 3B and data not shown).
Gene-specific knock-down with shRNAs reveals a role for
HAVCR1 in e-toxin-induced cytotoxicity
To provide further evidence that HAVCR1 contributes to e-
toxin-induced cytotoxicity, MDCK and ACHN cells were selected
that stably express shRNA constructs directed against HAVCR1
mRNA (Table 2). Despite repeated attempts, we were unable to
obtain MDCK cells stably transfected with the LOC12069-2
shRNA. Analysis of HAVCR1 mRNA by quantitative real-time
PCR confirmed that cells expressing HAVCR1-specific shRNA
exhibited reduced levels of HAVCR1 mRNA (Fig. 4A and B), and
immunoblotting confirmed that the cloned ACHN cells contained
reduced levels of HAVCR1 protein (Figure 4C). Furthermore,
MDCK and ACHN cells expressing reduced levels of HAVCR1
mRNA were more resistant to e-toxin than control cells (Fig. 4D
and E). ACHN cells transfected with shRNA to GAPDH also
exhibited a modest increase in resistance to the toxin compared to
the non-transfected control (Fig. 4E), perhaps due to an off-target
effect of the GAPDH shRNA or perhaps knocking down GAPDH
expression has a modest effect on sensitivity to e-toxin. The
reduced toxin sensitivity observed in cells exhibiting reduced
HAVCR1 mRNA or HAVCR1 protein provides further evidence
that HAVCR1 contributes to e-toxin-induced cytotoxicity.
HAVCR1 splice variants
We next examined the basis for the difference in the size of the
HAVCR1 protein expressed by toxin-sensitive ACHN and toxin-
resistant 769-P cells (Figure 3B). RNA was isolated from both cell
lines, transcript ends were mapped by 59-a n d3 9-RACE, and full-
length cDNAs were prepared and sequenced. A single 39 end to the
open reading frame was identified in e-toxin-sensitive ACHN cells,
corresponding to the canonical HAVCR1 protein (HAVCR1a,
Figure 5A). Two distinct 39 ends to the open reading frame were
identified in e-toxin-resistant 769-P cells; one transcript (HAVCR1a)
correspondedtothe canonicalsequencewhereasthesecond,shorter
Figure 1. MDCK insertional mutants with increased resistance
to e-toxin. An MDCK cell gene trap library was treated with purified e-
toxin as described in Materials and Methods. Clonal populations of
surviving cells were isolated, and treated with serial dilutions of purified
e-toxin. Cell viability was assessed as described in Materials and
Methods. Results represent the mean and standard deviation of
quadruplicate samples. To simplify the graphical display, results from
wild-type MDCK (&) and 5 representative mutant clones are displayed
(%,CCDC134;N, HAVCR1; #, SGMS2; m, XPO1; and n, ZBTB20); similar
results were observed for the remaining clones. The toxin dose needed
to kill 50% of each cell line was calculated by non-linear regression
analysis, and values were compared by ANOVA followed by Dunnett’s
post hoc test. Each of the selected mutant cell lines required a greater
amount of toxin to kill 50% of the cells than was required to kill 50% of
the parental MDCK cells (P,0.05).
doi:10.1371/journal.pone.0017787.g001
Table 1. Genes identified in e-toxin-resistant MDCK cells.
Gene Symbol
a Gene Name Aliases
BCL3 B-cell CLL/lymphoma 3 D19S37, BCL4
CAV2 Caveolin 2
CCDC134 Coiled-coil domain containing 134 FLJ22349
SMN
b
or
DUSP5
b
Survival of motor neuron
Dual specificity phosphatase 5 HVH3
HAVCR1 Hepatitis A virus cellular receptor 1 HAVCR-1, TIM-1, TIM1, HAVCR, TIMD1, KIM1
ZMYND8 Zinc finger, MYND-type containing 8 RACK7
SGMS2 Sphingomyelin synthase 2 MGC26963, SMS2
XPO1 Exportin 1 CRM1
ZBTB20 Zinc finger and BTB domain containing 20 ODA-8S, DKFZp566F123, DPZF
aGene nomenclature is based on recommendations of the HUGO Gene Nomenclature Committee at the European Bioinformatics Institute (http://www.genenames.org).
bThe gene trap vector in this clone inserted between the genes encoding SMN and DUSP5.
doi:10.1371/journal.pone.0017787.t001
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ed protein [42,43]. Although the proteins encoded by both
transcripts, HAVCR1a and HAVCR1b, are expected to have
similar extracellular domains, the cytoplasmic domain of the
HAVCR1a proteinincludes a tyrosine previously shown to undergo
phosphorylation in response to ligand stimulation [44,45];
HAVCR1b (the result of alternative splicing) includes a truncated
cytoplasmic domain lacking the phosphorylation motif (Figure 5B).
To confirm that the HAVCR1a transcript cloned from ACHN
cells expresses a protein similar in size to that identified by
immunoblotting ACHN cells, the cDNA encoding HAVCR1a from
ACHN cells was cloned into a mammalian expression vector and
transfected into HEK-293 cells. Non-transfected HEK-293 cells
express little, if any, HAVCR1 protein (Figures 3B and 5C),
whereas HEK-293 cells transfected with HAVCR1a cDNA express
a HAVCR1 protein similar in size to that expressed by toxin-
sensitive ACHN cells (Figure 5C).
Cloning and sequencing HAVCR1 cDNA from MDCK cells led
to the identification of 3 splice variants. The corresponding
proteins vary in the length of an internal mucin-like domain
(Figure 5C). Analysis of the amino acid sequences of HAVCR1a
from ACHN and MDCK cells revealed that the two species of
protein exhibit 50 to 60% amino acid identity within an amino-
terminal IgV-like domain and the carboxy-terminal transmem-
brane and cytoplasmic domains; the internal mucin-like domain,
though similar between the two species, varies considerably in
length between the two species (Figure 6).
e-toxin binds to HAVCR1
HEK-293 cells are resistant to e-toxin (Figure 3) and do not
express detectable amounts of HAVCR1 protein (Figures 2 and
5C). To begin to examine the contribution of HAVCR1 to e-toxin-
induced-cytotoxicity, we sought to determine whether expression of
Figure 2. HAVCR1 is more abundantly expressed in human kidney cells than in human cell lines resistant to e-toxin. A. Gene
expression data from a publicly-available microarray experiment were reported as fold increase over mean expression levels and included data for 8
genes listed in Table 1 [40,41]. Data was sorted based on tissue of origin and the mean expression level of each gene was determined for each tissue.
Results are expressed as the fold increase over the expression level observed in three control cell lines (A549, HEK-293, and HeLa) known to be
resistant to e-toxin. B. Gene expression data from a publicly-available microarray experiment reported as fold increase over mean expression levels
among all 83 cell lines are displayed for three cell lines known to be resistant to e-toxin (A549, HEK-293, and HeLa) and for 8 cell lines derived from
human kidney with unknown sensitivity to e-toxin [39].
doi:10.1371/journal.pone.0017787.g002
Figure 3. ACHN cells are sensitive to e-toxin. A. Cell lines, including human kidney cell lines expressing HAVCR1 based on publicly-available
microarray data or literature searches, were treated with serial dilutions of purified e-toxin. The canine kidney cell line MDCK (&) was included as a
positive control; HeLa (e) and HEK-293 (x) cells were included as negative controls. Other cell lines were 769-P (%), 786-O (N), A-498 (#), ACHN (m),
Caki-1 (n), and G-402 (¤). Cell viability was assessed as described in the Materials and Methods. Results represent the mean and standard deviation of
quadruplicate samples. B. Whole-cell lysates from e-toxin-sensitive ACHN and e-toxin-resistant 769-P and HEK-293 cells were prepared and equal
volumes of samples were analyzed by immunoblot analysis using an anti-HAVCR1 antibody.
doi:10.1371/journal.pone.0017787.g003
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293 cells were transfected with plasmid DNA expressing HAVCR1a
from e-toxin-sensitive ACHN cells. A cell-surface ELISA demon-
strated that the HAVCR1 protein was present on the cell surface of
the transfected cells at levels similar to that observed in toxin-
sensitive ACHN cells (Figure 7A). Surface expression of HAVCR1
was also demonstrated by immunofluorescence microscopy
(Figure 7B). However, the transfected HEK-293 cells remained
resistant to the cytotoxic effects of e-toxin (data not shown). These
results indicate that expression of HAVCR1 in toxin-resistant
HEK-293 cells is not sufficient to confer toxin sensitivity.
One possible role of HAVCR1 in e-toxin-induced cytotoxicity is
in promoting binding of the toxin to the cell surface. To examine
the potential interaction between e-toxin and HAVCR1, we
measured toxin binding to cells. Using a cell-surface ELISA,
e-toxin binding was detected on toxin-sensitive ACHN cells;
significantly less toxin bound to toxin-resistant HEK-293 cells
(Figure 7C). However, expression of HAVCR1a in HEK-293 cells
did not lead to a significant increase in the amount of toxin bound
to the cells (Figure 7C). Thus, transfection of HEK-293 cells with
HAVCR1a yielded a protein that bound specific antibodies to the
receptor, but not to the toxin.
As a complementary approach to examine the potential
interaction between e-toxin and HAVCR1, we assessed the ability
of the toxin to bind to the purified HAVCR1 extracellular
domain. To identify suitable control proteins, we used the DALI
Figure 4. HAVCR1 expression knockdown by shRNA. A. MDCK cells were stably transduced with a shRNA (LOC12069-1) targeting the HAVCR1
transcript. Quantitative real-time PCR was used to determine the amount of HAVCR1 transcript in the stably-transduced cell line compared to non-
transduced MDCK cells. Results of quadruplicate samples are shown. The asterisk denotes results that are significantly different from non-transfected
MDCK cells (p,0.05, ANOVA followed by Dunnett’s post hoc test). B. ACHN cells were stably transfected with a shRNA to GAPDH or two shRNAs
(21035 and 240418) targeting different regions of the HAVCR1 transcript. Quantitative real-time PCR was used to determine the amount of HAVCR1
transcript in the stably-transfected cell lines compared to non-transfected ACHN cells (control). Results summarize triplicate rt-PCR reactions from
each of three independent RNA samples per cell line. Asterisks denote results that are significantly different from non-transfected ACHN cells
(p,0.05, ANOVA followed by Dunnett’s post hoc test). C. Whole cell lysates from non-transfected and stably-transfected ACHN cells were
immunoblotted with an anti-HAVCR1 polyclonal antibody and with anti-b-actin as a control. The signal intensities from three different sets of lysates
were quantified by densitometry and are expressed as the mean ratio of HAVCR1 to b-actin (normalized to non-transfected ACHN cells). Asterisks
denote results that are significantly different from non-transfected ACHN cells (p,0.05, ANOVA followed by Dunnett’s post hoc test). D. Non-
transduced MDCK cells (&) and MDCK cells stably-transduced with shRNA targeting HAVCR1 (%, LOC12069-1) were treated with serial dilutions of
purified e-toxin. Cell viability was assessed as described in Materials and Methods. Results represent the mean and standard deviation of at least
quadruplicate samples. The toxin dose needed to kill 50% of each cell line was calculated by non-linear regression analysis, and values were
compared by Student’s t-test. The MDCK cells transfected with HAVCR1 shRNA required a greater amount of toxin to kill 50% of the cells than was
required to kill the parental MDCK cells (P,0.0005). E. Cells (&, ACHN; %, ACHN cells transfected with shRNA to GAPDH;N, ACHN cells transfected
with HAVCR1 shRNA 21035; #, ACHN cells transfected with HAVCR1 shRNA 240418) were treated with serial dilutions of purified e-toxin. Cell viability
was assessed as described in the Materials and Methods. Results represent the mean and standard deviation of quadruplicate samples. The toxin dose
needed to kill 20% of cells was calculated by non-linear regression analysis and values were compared by ANOVA followed by Dunnett’s post hoc test
(the dose needed to kill 20% of the monolayer was determined rather than the dose needed to kill 50% as completing the dose response curve for
cells transfected with HAVCR1 shRNA would require considerable amounts of toxin). The ACHN cells transfected with HAVCR1 shRNA required a
greater amount of toxin to kill 20% of the cells than was required to kill 20% of the parental ACHN cells or cells transfected with GAPDH shRNA
(P,0.05). The toxin dose required to kill 20% of cells transfected with GAPDH shRNA was not significantly different than the dose required to kill 20%
of wild-type ACHN cells.
doi:10.1371/journal.pone.0017787.g004
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HAVCR1 IgV-like domain to other human proteins [46,47].
Three proteins (CD4, CXADR, and HAVCR2) were selected as
the most similar structures to the HAVCR1 IgV-like domain. The
calculated root mean square distances (RMSD) between
HAVCR1 and CD4, CXADR, and HAVCR2 were 2.3, 1.9,
and 1.3, respectively [46,47,48,49,50]. Although the tertiary
structures of these proteins are similar, the primary amino acid
sequences exhibit little similarity to the sequence of HAVCR1
(Figure 8A). Highly purified recombinant, human HAVCR1
extracellular domain or recombinant extracellular domains of
CD4, CXADR, or HAVCR2 were conjugated to Dynabeads
(Figure 8B). The protein conjugated beads then were mixed with
purified e-toxin Immunoblotting of eluted proteins indicated that
e-toxin bound to HAVCR1 coated beads, bound to a much lesser
extent to CD4, but failed to bind to beads coated with CXADR or
HAVCR2 (Figure 8C). These results indicate that e-toxin can bind
to the extracellular domain of HAVCR1.
Discussion
The interactions between e-toxin and mammalian cells leading
to cell death are incompletely understood. Although evidence
suggests that e-toxin binds to a specific receptor on the surface of
sensitive cells, the toxin also has been shown to form pores in
protein-free liposomes [51]. In addition, the mechanism by which
e-toxin induces cell death is unclear. A previous study reported the
isolation of spontaneous MDCK and G-402 cell variants with
increased resistance to the e-toxin, and two-dimensional PAGE
revealed differences in the proteins expressed by sensitive and
resistant cells [52]. However, the identities of these proteins and
experiments confirming that these differences contributed to
e-toxin sensitivity were not reported. The present study confirms
that host factors contribute to e-toxin-induced cytotoxicity and
identifies genes encoding several of these host factors. By
identifying such host factors, this study illustrates that the lethal
activity of the toxin is not simply a direct result of the pore-forming
activity of the toxin.
Analysis of gene-expression microarray data led us to focus on
one particular gene, HAVCR1, to use as an example to further
validate the experimental approach. Cytotoxicity testing on cells
expressing HAVCR1 led to the identification of a human cell line,
ACHN, which is sensitive to e-toxin. The identification of e-toxin-
Table 2. HAVCR1 shRNAs.
Name Sequence
a Location
Canis familiaris
LOC12069-1 TCCCATTGCTTAGAAGAAATA Exon 2
LOC12069-2 GGTTCAATGACATGAAACTCA Exon 2
Homo sapiens
V2LHS_21035 CTGTGTATAGTCAACCTCA 39 UTR
V2LHS_240418 GCCAATACCACTAAAGGAA Exon 6
aThe sequence of the sense strand of the shRNA hairpin is provided.
doi:10.1371/journal.pone.0017787.t002
Figure 5. HAVCR1 splice variants. A. Full-length cDNAs were cloned and sequenced from e-toxin-sensitive ACHN cells (HAVCR1a) and from
e-toxin-resistant 769-P cells (HAVCR1a and HAVCR1b). The coding-exon structure for each transcript is illustrated. B. Partial amino acid sequences of
the HAVCR1a and HAVCR1b proteins are shown; the putative cytoplasmic domains are boxed. A conserved tyrosine present in HAVCR1a, shown
previously to become phosphorylated, is underlined [44,45]. C. Whole-cell lysates were prepared from e-toxin-sensitive ACHN, from e-toxin-resistant
769-P and HEK-293 cells, and from HEK-293 cells transfected with a vector expressing HAVCR1a from ACHN cells and analyzed by immunoblot
analysis using an anti-HAVCR1 antibody. D. Full-length cDNAs were cloned and sequenced from e-toxin-sensitive MDCK cells. The coding-exon
structures for the three transcripts are illustrated as in ‘‘A’’.
doi:10.1371/journal.pone.0017787.g005
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17787sensitive ACHN cells provides an important experimental system
with which to study the interaction between e-toxin and human
cells.
Results of the present study establish that HAVCR1 contributes
to e-toxin-induced cytotoxicity. Disruptionof HAVCR1expression,
whether by gene-trap insertion or by RNA interference strategies in
toxin-sensitive human and canine cell lines, led to increased
resistance to e-toxin-induced cytotoxicity. In addition, the toxin
was found to bindwith greater avidity to the extracellular domainof
HAVCR1 than to structurally similar proteins, suggesting that
HAVCR1 may serve as a receptor or co-receptor for the toxin.
Whereas HAVCR1 also has been identified as a receptor for the
hepatitis A virus [42,43], it is possible that HAVCR1 participates in
an alternate role. For example, HAVCR1 might participate in
intracellular signal transduction in response to e-toxin binding or to
dysregulated ion flux through toxin pores [44,45], or might
participate in (or stabilize) protein-protein interactions that
contribute to e-toxin-induced cytotoxicity [53,54].
Though we have demonstrated that HAVCR1 contributes to e-
toxin-induced cytotoxicity, expression of HAVCR1 in HEK-293
cells (a cell line that is naturally resistant to the toxin and which
expresses undetected levels of HAVCR1) did not confer increased
toxin binding or toxin sensitivity. Multiple explanations may
account for this. For example, glycosylation is important for both
e-toxin binding to cells and for binding of hepatitis A virus to
HAVCR1 [19,55]. Thus, differences in the post-translational
modification of HAVCR1 in ACHN and HEK-293 cells could
alter toxin binding. Alternatively, HEK-293 cells may express one
or more molecules that inhibit the binding or subsequent activity
of the toxin. Such a cell-specific dominant phenotype has been
observed previously in response to the cytocidal effect of tumor
necrosis factor and in HIV virus replication [56,57,58]. Finally,
HEK-293 cells may be deficient in one or more unidentified host
factors (in addition to HAVCR1) contributing to e-toxin-induced
cytotoxicity. A similar complexity of interactions between a toxin
and a host cell is illustrated by the identification of multiple factors
contributing to the activity of the anthrax toxins [59,60,61,62]. In
support of these alternatives, analysis of publicly-available gene-
expression microarray data reveals numerous genes expressed at
higher levels in toxin-resistant HEK-293 cells than in toxin-
Figure 7. HAVCR1 expression in transfected HEK-293 cells. A. Expression of HAVCR1 in ACHN, HEK-293, and HEK-293 cells transfected with
plasmid DNA expressing HAVCR1a from ACHN cells was detected by a cell-surface ELISA [43]. Representative results are presented as the mean and
standard deviation of triplicate samples. The asterisk denotes results that are significantly less than the signal from toxin-sensitive ACHN cells
(p,0.05, ANOVA followed by Dunnett’s post hoc test). B. Expression of HAVCR1 on ACHN, HEK-293, and HEK-293 cells transfected with plasmid DNA
expressing HAVCR1a from ACHN cells was detected by fluorescence microscopy as described in Materials and Methods. Green: HAVCR1; red: 7-AAD.
C. Binding of e-toxin to ACHN, HEK-293, and HEK-293 cells transfected with plasmid DNA expressing HAVCR1a from ACHN cells was detected by a
cell-surface ELISA. Representative results are presented as the mean and standard deviation of triplicate samples. The asterisks denote results that are
significantly less than the signal from toxin-sensitive ACHN cells (p,0.05, ANOVA followed by Dunnett’s post hoc test).
doi:10.1371/journal.pone.0017787.g007
Figure 6. Amino acid sequence alignment of human and canine HAVCR1 splice variants. The predicted amino acid sequences of HAVCR1
proteins from human ACHN and 769-P cells and from canine MDCK cells were aligned using ClustalW. These sequences have been deposited in
GenBank as accession numbers HQ412639 (HAVCR1a, ACHN cells), HQ412640 (Havcr1a, 769-P cells), HQ412641 (HAVCR1b, 769-P cells), HQ412642
(HAVCR1a, MDCK cells), HQ412643 (HAVCR1b, MDCK cells), and HQ412644 (HAVCR1c, MDCK cells).
doi:10.1371/journal.pone.0017787.g006
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PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e17787sensitive ACHN cells ([40,41]and data not shown). The same data
also reveals genes expressed at higher levels in ACHN cells than in
HEK-293 cells, including genes encoding proteins known to
interact with HAVCR1 ([40,41,53,54] and data not shown). We
currently are determining whether these proteins, like HAVCR1,
also contribute to e-toxin-induced cytotoxicity.
Variability in HAVCR1 previously has been associated with
susceptibility to allergic diseases [63], and also may be associated
with susceptibility to infectious diseases [64,65,66,67]. Whether
e-toxin has provided a selective pressure contributing to such
variability in HAVCR1 is unclear. However, results of the present
study suggest a correlation between the expression of a particular
HAVCR1 splice variant and sensitivity to the e-toxin. The
recombinant HAVCR1 shown to bind e-toxin coincides with the
extracellular domain of the protein. The extracellular domains of
the HAVCR1a and HAVCR1b variants we identified differ by a
single amino acid (Figure 6), suggesting that the toxin either binds
to both human isoforms of HAVCR1 characterized in this study,
or that this single amino acid is critical for the toxin interaction.
The region of least similarity between the HAVCR1a protein
expressed by e-toxin-sensitive ACHN cells and the shorter
HAVCR1b protein identified in e-toxin-resistant 769-P cells
resides within the protein’s cytoplasmic domain. The cytoplasmic
domain in HAVCR1a includes a tyrosine previously shown to be
subject to phosphorylation in response to relevant stimulation [44]
and required for heterotypic protein-protein interactions [53]. A
similar tyrosine is found in the cytoplasmic domain of the
HAVCR1 protein variants identified in e-toxin-sensitive MDCK
cells. Further experiments are needed to identify additional cell
lines, beyond ACHN, that express the HAVCR1a variant and to
assess the sensitivities of such cell lines to e-toxin.
This study presents the combined use of gene trap insertional
mutagenesis and RNA interference to identify mammalian genes
that contribute to the cytotoxic activity of a bacterial pore-forming
toxin. Whereas previous studies using a similar approach have
emphasized use of hypodiploid cell lines [34,35], the present study
demonstrates that a forward genetic approach may be employed
using a common diploid cell line to perform a genome-wide survey
identifying mammalian genes contributing to the activity of a
bacterial protein toxin. Additional characterization of HAVCR1
and the other host factors identified in the present study is
expected to provide insight into the mechanism of e-toxin-induced
cell death. For example, one of the genes identified and reported in
this study was the gene encoding sphingomyelin synthase 2, whose
product catalyzes the last step in the synthesis of sphingomyelin. A
previous study has demonstrated that D609, an inhibitor of
sphingomyelin synthase, inhibits e-toxin-induced cytotoxicity [38].
Thus, the identification of this gene among our set of cells with
increased resistance to the e-toxin provides additional validity to
the method. In addition, we also identified the gene encoding
caveolin 2, in which shRNA knock down experiments validate a
role for this protein in toxin activity (manuscript in preparation).
Although caveolin 2, along with caveolin 1, is most frequently
considered in its role in endocytosis of caveolae, multiple studies
have reported being unable to detect internalization of e-toxin into
sensitive cells [21,22,24]. Insight into the role caveolin 2 plays
might come from studies of another pore-forming toxin. For
example, the Staphylococcus aureus a-toxin has been demonstrated to
bind to caveolin 1, and mutant a-toxins that are disrupted in the
ability to bind caveolin 1 are non-hemolytic [68,69,70]. Further
studies are needed to determine the precise role caveolin 2 plays in
e-toxin-induced cytotoxicity. Many of the other genes identified in
the present study appear to be involved in intracellular signal
transduction and gene transcription. Additional studies are in
progress to confirm a role for these genes in e-toxin-induced
cytotoxicity and to further explore the signal-transduction path-
ways and transcriptional response of intoxicated cells. The data
presented in this paper indicate that mammalian genes may be
important participants to the activity of bacterial toxins, and may
serve as targets for therapeutics.
Materials and Methods
Cell culture
MDCK, HeLa, ACHN, HEK-293, and A-498 cells were
cultured in MEM. 769-P and 786-O cells were cultured in RPMI.
Caki-1 and G-402 cells were cultured in McCoy’s 5A. All cell lines
were obtained from ATCC, and all culture media were
supplemented with 10% serum (Fetal Clone III, HyClone).
Gene trap library construction
The U3neoSV1 retrovirus vector [36] was obtained from Zirus,
Inc. (Buford, GA). Toxin-sensitive MDCK cells were infected in
T75 flasks at 37uC for 1 hour with U3neoSV1 (MOI=0.1) in the
presence of 4 mg/ml Polybrene (Sigma, St. Louis, MO).
Subsequently, the medium was changed and the cells were grown
overnight at 37uC. On the following day, G418 selection was
initiated and cells were grown to confluence.
Generation of e-toxin-resistant MDCK cells from the gene
trap library
MDCK cells transfected with the gene trap vector were plated in
nine 100 mm dishes (approximately 3.3610
6 cells per dish) in
Leibovitz’s L-15 medium. Toxin was added to a final concentration
of 20 nM, and the treated cells were incubated at 37uC for
16 hours. The toxin-containing medium was replaced with fresh
medium and surviving cells were cultured for 2 days. Medium then
was replaced with fresh Leibovitz’s L-15 containing 35 nM e-toxin,
and the cells were incubated for 16 hours. The toxin-containing
medium was replaced with fresh medium and surviving cells were
cultured for 3 days. Medium then was replaced with fresh
Leibovitz’s L-15 containing 50 nM e-toxin, and the cells were
incubated for 16 hours. Medium then was replaced with fresh
Leibovitz’s L-15 (with no added toxin) and cells that survived
exposure to e-toxin were allowed to grow 7 days before clonal
populations were isolated. Clonal populations were isolated by
limiting dilution into multiwell plates, followed by microscopic
examination to identify wells receiving a single cell. These single
cells then were propagated to provide sufficient cells for analysis.
The cloning of a single integrated gene-trap vector from each of the
toxin-resistant cell lines confirmed the clonal nature of the cell lines.
Figure 8. HAVCR1 binds to e-toxin. A. The amino acid sequences of the recombinant extracellular domains of HAVCR1, HAVCR2 (TIM-3), CD4,
CXADR were aligned using ClustalW. Despite similar tertiary structures, the proteins exhibit little primary amino acid sequence similarity. B. Equal
amounts (0.5 mg) of the recombinant extracellular domains of HAVCR1, HAVCR2 (TIM-3), CD4, CXADR were separated by SDS-PAGE and the gel was
stained with Simply Blue SafeStain (Invitrogen) demonstrating the purity of each protein preparation. C. Recombinant human extracellular domains
of HAVCR1, CD4, CXADR, or HAVCR2 (TIM-3) were conjugated to paramagnetic beads as described in Materials and Methods. Purified e-toxin was
incubated with each conjugated bead preparation. The bound proteins were eluted by boiling in SDS, and detected by immunoblotting with anti-
e-toxin antiserum.
doi:10.1371/journal.pone.0017787.g008
Host Factors Contributing to e-Toxin Activity
PLoS ONE | www.plosone.org 10 March 2011 | Volume 6 | Issue 3 | e17787U3neoSV1 shuttle vector rescue, sequencing, and
analysis
Cellular DNAs from clonal toxin-resistant cell lines were
extracted using a QIAamp DNA Blood Maxi kit (QIAGEN,
Inc., Valencia, CA). Shuttle vectors and genomic DNA flanking
the integration site were recovered by digestion of the genomic
DNA (150 mg/ml) with EcoRI or BamHI, self-ligation, transfor-
mation into Escherichia coli, and selection on Luria broth agar
containing 100 mg per ml carbenicillin (Sigma). Individual colonies
were amplified, and recovered genomic DNAs were sequenced
using primers annealing to the gene-trap shuttle vector. Sequenc-
ing reactions were performed using an ABI BigDye Terminator
cycle sequencing kit, and sequences were analyzed using an ABI
3100 genetic analyzer (Applied Biosystems, Foster City, CA). The
sequences of the sequencing primers are available upon request.
Genomic sequences obtained from shuttle clones were analyzed by
the RepeatMasker web server, followed by nucleotide-nucleotide
BLAST searches against the National Center for Biotechnology
Information databases.
Transfections and transductions
Plasmid DNAs encoding shRNAs were transfected into ACHN
cells using Lipofectamine 2000 (Invitrogen). Pseudoviral particles
encoding shRNAs were purchased from Sigma-Aldrich and
transduced into MDCK cells. The sequences and locations of
shRNAs are listed in Table 2. Plasmid DNA (pCMV-Script,
Stratagene) encoding the HAVCR1 protein from ACHN cells was
transfected into HEK-293 cells using Lipofectamine LTX
(Invitrogen).
Real-time quantitative PCR
Cells were treated with RNALater (Ambion) according to the
manufacturer’s instructions. Total cellular RNA was isolated from
the treated cells with TriZol reagent (Invitrogen). Complementary
DNA (cDNA) was prepared from 2 mg total RNA using
Omniscript RT (Qiagen). Quantitative real-time PCR was
performed using gene-specific primer sets from Applied Biosystems
and a StepOne Plus instrument (Applied Biosystems). A primer set
specific to 18S rRNA was used as control. Results were analyzed
by comparing CT values [71].
e-toxin purification and cytotoxicity assays
Previous studies have demonstrated that native and recombi-
nant e-toxin produced in E. coli exhibit similar specific activities in
standard tissue-culture based assays of toxin activity
[20,37,72,73,74,75]. Recombinant e-prototoxin was expressed in
E. coli K12 strain NovaBlue (DE3) (Novagen), and purified
essentially as described [74,75]. The cells were collected by
centrifugation, resuspended in 5% culture volume of B-PER
Bacterial Protein Extraction Reagent (Pierce) supplemented with
Complete Mini protease inhibitor cocktail (EDTA-free, Roche),
and mixed for 10 minutes at room temperature. Omnicleave
nuclease (Epicentre) was added to reduce the viscosity of the
samples. The cell debris was pelleted, and the supernatant was
recovered. The B-PER extracted material was diluted four-fold
with water, and applied to a Q-Sepharose column. The e-
prototoxin-containing flow-through material was collected and
applied to a Ni-NTA affinity column (Qiagen). The Ni-NTA
column was washed with a buffer comprised of 50 mM sodium
phosphate, 300 mM sodium chloride, and 20 mM imidazole
(pH 8.0), and the e-prototoxin was eluted in a buffer comprised of
50 mM sodium phosphate, 300 mM sodium chloride, and
250 mM imidazole (pH 8.0). The identification of the e-proto-
toxin in the purified sample was confirmed by immunoblotting
with e-toxin-specific monoclonal antibody. Protein concentrations
were determined using micro-BCA (Pierce).
The e-prototoxin can be cleaved with trypsin to remove short
peptides from both the amino- and carboxy-terminal ends of the
protein to yield the active e-toxin [20,74,75,76,77]. Trypsin-
coated agarose beads (Pierce) were washed and resuspended in
5 mM Tris, pH 7.5. Preparations containing the e-prototoxin
were incubated with trypsin-agarose at 37uC for 60 minutes, the
trypsin-coated beads were removed by centrifugation, and residual
trypsin was inhibited by Complete Mini protease inhibitor cocktail
(Roche). Conversion of the e-prototoxin to e-toxin was assessed
based on SDS-PAGE and immunoblotting with anti- e-toxin
antibodies.
Cytotoxicity was determined based on assessing cellular
metabolic activity as described [75]. Cells in Leibovitz’s L-15
medium supplemented with 10% fetal bovine serum were added
to multiwell plates (5610
3 cells per well in 384-well dishes) and
incubated at 37uC. Following cell attachment, e-toxin was added,
and the cells then were incubated at 37uC for 16 hours. Cytoto-
xicity was determined by treating cells with resazurin (CellTiter
Blue, Promega) at 37uC for 4 hours. Fluorescence at 590 nm was
measured following excitation at 560 nm using a BioTek FLx800
plate reader. Results were normalized to the fluorescent signal
from cells incubated in the absence of toxin (100%) and in 0.1%
Triton X-100 (0%).
RACE analysis
The 59- and 39-ends of HAVCR1 transcripts in ACHN and
769-P cells were determined by RACE analysis using First Choice
RLM RACE (Ambion) and DNA sequences were determined
(GenHunter).
Bead binding assay
Recombinant proteins (R & D Systems) were conjugated to
tosyl-activated Dynabeads according to the manufacturer’s
instructions (Invitrogen). To compare the efficiency of protein
conjugation to the beads, the protein concentration of an aliquot
of each bead preparation was determined using the micro BCA
assay (Pierce); the amount of bound protein varied by less than
5%. For capturing e-toxin from solution, coated beads in Tris-
buffered saline supplemented with 0.1% tween-20 and 0.1% BSA
were mixed with purified e-toxin. Beads were incubated with the
toxin at room temperature for 1 hour, with agitation. The beads
then were captured, washed 3 times in Tris-buffered saline
containing 0.1% tween-20. The washed beads then were heated in
SDS-sample buffer to elute bound toxin, and samples were
analyzed by SDS-PAGE followed by immunoblotting with anti-
e-toxin antiserum.
Immunological reagents
Anti-Clostridium perfringens C/D (Boerhinger-Ingelheim) equine
antiserum was used to detect purified e-toxin in immunoblots;
mouse monoclonal antibody 4D7 was used to detect e-toxin
bound to cells [78]. Mouse monoclonal antibody to human
HAVCR1 (Tim-1, R & D Systems), and rabbit polyclonal
antibody to b-actin (Abcam) were used as primary antibodies for
the detection of HAVCR1, and b-actin, respectively. HRP-
conjugated donkey anti-rabbit (GE Healthcare), donkey anti-goat
(Abcam), and rabbit anti-horse (Sigma-Aldrich) were used as
secondary antibodies. SuperSignal West Pico and SuperSignal
West Femto (Thermo Scientific) were used for enhanced
chemiluminescent detection.
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A cell-surface ELISA was used to detect surface expression of
HAVCR1 [43]. Cells were detached from tissue culture flasks
using 0.2% EDTA in 0.9% NaCl. Cells were transferred to 96 well
V-bottom plates at 3610
5 cells per well. Cells then were fixed with
0.08% glutaraldehyde for 15 minutes at room temperature. Cells
were washed with PBS, and incubated with PBS containing 5%
BSA for 30 minutes at room temperature. HAVCR1 was detected
with mouse anti-HAVCR1 monoclonal antibody (R & D Systems)
for one hour at room temperature and horseradish peroxidase-
labeled anti-mouse IgG (45 minutes at room temperature)
followed by TMB substrate (Pierce). The signal from control cells
treated with the secondary antibody only was subtracted.
A similar approach was used to detect e-toxin binding to cells.
Fixed cells were washed with PBS, and toxin was added to
625 nM for 15 minutes at 37uC. After removal of unbound toxin,
cells were incubated with PBS containing 5% BSA for 30 minutes
at room temperature. Bound e-toxin was detected with mouse
anti- e-toxin monoclonal antibody 4D7 [78]. Cells were incubated
with anti- e-toxin antibody for one hour at room temperature and
horseradish peroxidase-labeled anti-mouse IgG (45 minutes at
room temperature) followed by TMB substrate (Pierce). The signal
from control cells, in the absence of added toxin was subtracted.
Fluorescence Microscopy
Cells were grown on an 8-well chamber slide (Nunc) to 20%
confluency. Cells were washed with warm HBSS (0.137 M NaCl,
5.4 mM KCl, 0.25 mM Na2HPO4, 0.44 mM KH2PO4, 1.3 mM
CaCl2, 1.0 mM MgSO4, 4.2 mM NaHCO3) and incubated with
anti-HAVCR1 mouse monoclonal antibody (R&D Systems) in
MEM with 10% FBS for 1 hour at 37uC. The media was removed
from each well and cells subsequently were fixed in 4%
formaldehyde in HBSS for 10 minutes at 37uC. Cells were washed
3 times with warm HBSS and permeabilized by incubation with
0.25% Triton-X 100 (Sigma-Aldrich) in HBSS for 5 minutes at
37uC. Cells were washed with warm HBSS and subsequently
blocked for 30 minutes at 37uC with 10% goat serum (Sigma-
Aldrich) in HBSS. The cells were washed 3 times with HBSS, and
incubated in the dark with Alexa Fluor 488-conjugated goat anti-
murine IgG (Invitrogen) diluted in MEM with 10% FBS for 1 hour
at 4uC. Cells were washed 3 times with HBSS then each well was
incubated with 7-AAD nuclear stain (BD Pharmingen) for
15 minutes at 37uC in the dark. Cells were washed 3 times in
HBSS, the chambers were removed, and a coverslip was mounted
with Fluoro-Gel (Electron Microscopy Sciences). Imaging was
performed on a Zeiss LSM 510 inverted confocal microscope.
Select agent
Plasmid DNA capable of expressing the e-prototoxin (or e-toxin)
is considered a select agent by the U.S. Department of Health and
Human Services.
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